InsiderTrades

Form 4 for TMCI TREACE MEDICAL CONCEPTS, INC.

Accepted 2026-01-23 00:00:00 ET · period of report 2026-01-22 · accession 0001193125-26-021449 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
2026-01-23 2026-01-22 TMCI Treace John T. CEO, Dir, 10% F - Tax $0.00 -14.3K 6.76M -0.2% $0
2026-01-23 2026-01-22 TMCI Treace John T. CEO, Dir, 10% A - Grant $0.00 +250.0K 7.01M +4% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-01-22 F D 14,254 $0.00 6,761,633 D — — (F1) Includes 321,871 restricted stock units.
2 Common Common Stock 2026-01-22 A A 250,000 $0.00 7,011,633 D — — (F2) Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, with the first installment vesting on January 22, 2027 and the last installment vesting on January 22, 2030; subject to Reporting Person's providing continued service to Issuer through each vesting date. (F3) Includes 571,871 restricted stock units.